首页 | 本学科首页   官方微博 | 高级检索  
检索        

血清胱抑素C在2型糖尿病肾病早期诊断中的临床价值探讨
引用本文:周蓓,陈学峰,杭宇,方晨圆,鲁大胜,陶少平.血清胱抑素C在2型糖尿病肾病早期诊断中的临床价值探讨[J].实用全科医学,2014(9):1379-1381.
作者姓名:周蓓  陈学峰  杭宇  方晨圆  鲁大胜  陶少平
作者单位:皖南医学院第二附属医院内分泌科,安徽省芜湖市241000
基金项目:皖南医学院中青年科研基金(WK2013F31); 安徽省高校自然科学基金(KJ2013B305)
摘    要:目的探讨血清胱抑素C在早期诊断2型糖尿病患者肾损伤的临床价值,同时分析血清胱抑素C与肾小球滤过率之间的关系。方法选择100例皖南地区2型糖尿病患者,根据所选患者24小时尿白蛋白排泄率,将患者分为正常白蛋白尿组(32例)、微量白蛋白尿组(39例)及大量白蛋白尿组(29例)。分别检测3组患者的血清胱抑素C、血尿素氮、血肌酐、肌酐清除率及肾小球滤过率等临床指标,同时对血清胱抑素C与肾小球滤过率的相关性进行统计学分析。结果在所选皖南地区2型糖尿病患者中,随着患者24小时尿白蛋白排泄量的增加,3组患者的肾小球滤过率及肌酐清除率均出现明显降低,血清胱抑素C水平出现升高,并与肾小球滤过率呈现明显的负相关性(P〈0.01)。而且血清胱抑素C、肾小球滤过率、肌酐清除率存在显著性差异;在单纯性2型糖尿病患者中,血肌酐及血尿素氮的检出率均较低,但肾小球滤过率不同的患者,胱抑素C水平却有明显差别,eGFR〈60 ml/(min·1.73 m^2)患者的血清CysC水平明显高于eGFR≥60 ml/(min·1.73 m^2)的患者,且该差异具有统计学意义。结论血清胱抑素C是一种能灵敏反映肾小球滤过率的内源标记物,其不仅与肾小球滤过率呈现良好的临床相关性,而且能反映2型糖尿病患者的不同肾损伤程度,进而用于单纯性2型糖尿病患者肾小球滤过率下降的早期诊断。

关 键 词:糖尿病肾病  血清胱抑素C  血肌酐  蛋白尿

Clinical value of serum cystatin C in early diagnosis of diabetic nephropathy in type 2 diabetes
Institution:ZHOU Bei, CHEN Xue-feng, HANG Yu ,et al.( Department of Endocrinology, the Second Affiliated Hospital of Wannan Medical College, Wuhu 241000,Anhui, China)
Abstract:Objective To discuss the clinical value of serum cystatin C( CysC) in the early diagnosis of renal impairment in patients with type 2 diabetes,and analyze the relationship between serum CysC level and glomerular filtration rate( eGFR). Methods According to 24 h urines albumin excretion rate,100 type 2 diabetic patients in southern Anhui areas were divided into non-albuminuria group( n = 32),microalbuminuria group( n = 39) and macroalbuminuria group( n =29). The levels of serum CysC,blood urea nitrogen( BUN),serum creatinine( Scr),creatinine clearance rate( Ccr) and eGFR of the three groups were tested. The correlation between eGFR and serum Cys C was also analyzed statistically. Results Among the three groups,both eGFR and Ccr declined with the increasing of 24 h urines albumin excretion rate,but the CysC level increased and presented a negative correlation with eGFR( P 〈0. 01). There was also a significant difference in serum CysC,eGFR and Ccr among the three groups. The detection rates of Scr and UBN were low for type 2 diabetic patients with non-albuminuria,but there was obvious difference of CysC for the patients with different eGFR. The CysC level of the patients with eGFR 60 ml /( min·1. 73 m^2) was apparently higher than that of the patients with eGFR≥60 ml /( min·1. 73 m^2),and this difference was statistical significance. Conclusion The serum CysC was a sensitive endogenesis marker of eGFR,it not only had a good clinical correlation with eGFR,but also showed the different degree of renal impairment for type 2 diabetic patients,and can early diagnose the decline of eGFR in type 2 diabetic patients with non-albuminuria.
Keywords:Diabetic nephropathy  Serum cystatin C  Serum creatinine  Albuminuria
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号